Recent treatment patterns in US-based real-world patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...
Mutations accumulate in the genome of every cell of the body throughout life, causing cancer and other genetic diseases. Almost all of these mosaic mutations begin as nucleotide mismatches or damage ...
Utilization of neoadjuvant chemotherapy (NAC) and pathologic outcomes in upper tract urothelial carcinoma (UTUC). No visceral or thoracic lesions (n=86) 20.9 (19.7-NE) 10.6 (6.0-NE) 11.0 (8.2-20.4) ...
Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function ...
For more than a century, heredity has been framed through the tidy logic of Mendel’s pea plants: traits pass from parent to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results